Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FBN3 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | DNAJC7 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | TMEM179 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | AUTS2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | MADD | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
mRNA | CASD1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | PFDN2 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | ZNF362 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | DUS2 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |